A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
While they can’t predict the future, financial advisors are placing their bets on active investments, quantum computing, and more.
As retail investors booms, advisors are balancing full-service offerings with more hands-on advice options.
Investors have plenty of choices to gain exposure to the Magnificent 7, depending on how much risk or reward they choose to take.